CD274 and Sepsis: In mouse models of sepsis, anti-PD-1 and anti-PD-L1 antibody treatments have been shown to increase pathogen clearance, restore protective immune responses, and improve survival [199-201], while ex vivo experiments using cells from patients with sepsis have revealed that PD-1 or PD-L1 pathway blockade decreases sepsis-induced immune dysfunction [202].